# First Merchants Corp: overview FRME · Nasdaq · CIK 712534 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/frme.md) · [Financials](/companies/frme/financials.md) · [Filings](/companies/frme/filings.md) · [Insiders](/companies/frme/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.68](/filings/0000712534-25-000171.md) | [0.84](/filings/0000712534-25-000197.md) | not reported | [0.94](/filings/0000712534-26-000035.md) | [0.98](/filings/0000712534-25-000171.md) | [0.98](/filings/0000712534-25-000197.md) | not reported | [0.45](/filings/0000712534-26-000035.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [3.81](/filings/0000712534-24-000071.md) | [3.81](/filings/0000712534-25-000058.md) | [3.73](/filings/0000712534-26-000022.md) | [3.41](/filings/0000712534-26-000022.md) | [3.88](/filings/0000712534-26-000022.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/frme/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $232.6m | 5,324,728 | | Added +425,372 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $161.2m | 3,689,776 | | Added +93,759 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $148.7m | 3,402,832 | | Added +43,798 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $118.9m | 2,720,680 | | Reduced −9,931 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $111.5m | 2,551,308 | | Added +311,540 | | [EARNEST PARTNERS LLC](/funds/1102578.md) | 2026-06-30 | $95.0m | 2,174,024 | | Reduced −81,566 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $73.0m | 1,670,991 | | Added +97,210 | | [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $46.3m | 1,058,876 | | Added +15,553 | | [VICTORY CAPITAL MANAGEMENT INC](/funds/1040188.md) | 2026-06-30 | $45.6m | 1,042,728 | | Added +47,733 | | [SYSTEMATIC FINANCIAL MANAGEMENT LP](/funds/1085936.md) | 2026-06-30 | $37.2m | 850,405 | | Reduced −11,590 | ## Recent filings [All 2,571 filings](/companies/frme/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 15:43 ET | [10-Q](/filings/0000712534-26-000077.md) | Quarterly report, period 2026-09-30 | 0000712534-26-000077 | | 2026-10-21 | 16:08 ET | [8-K](/filings/0000712534-26-000073.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000712534-26-000073 | | 2026-10-15 | 15:09 ET | [8-K](/filings/0000712534-26-000070.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000712534-26-000070 | | 2026-10-01 | 08:12 ET | [8-K](/filings/0000712534-26-000067.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000712534-26-000067 | | 2026-09-25 | 14:10 ET | [8-K](/filings/0001193125-26-402604.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-402604 | | 2026-09-24 | 18:22 ET | [8-K](/filings/0001193125-26-399714.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-399714 | | 2026-08-14 | 16:09 ET | [8-K](/filings/0000712534-26-000064.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000712534-26-000064 | | 2026-07-31 | 12:31 ET | [10-Q](/filings/0000712534-26-000059.md) | Quarterly report, period 2026-06-30 | 0000712534-26-000059 | | 2026-07-22 | 16:12 ET | [8-K](/filings/0000712534-26-000056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000712534-26-000056 | | 2026-07-13 | 16:33 ET | [8-K](/filings/0000712534-26-000051.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000712534-26-000051 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000712534-26-000022.md), filed Feb 25, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 712534 - Tickers: FRME, FRMEP - Exchange: Nasdaq - SIC code: 6021 National Commercial Banks - State of incorporation: IN - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 15:44 ET. No prices; not investment advice.